# LITHIUM CARBONATE
> **ANDA079139** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2009-02-03
## Drug
- **FDA Application Number:** ANDA079139
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LITHIUM CARBONATE
- **Generic name:** LITHIUM CARBONATE
- **Active ingredients:** LITHIUM CARBONATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2009-02-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079139)
---
*AI Analytics · CC0 1.0*